Showing results (191-200 of 377) with videos related to

Sort By:
Pageof 38
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 22, 2006
Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis developmentHitoshi Yoshiji, Shigeki Kuriyama, Ryuichi Noguchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesisRyuichi Noguchi, Hitoshi Yoshiji, Shigeki Kuriyama, et al.
International Journal of Molecular Medicine|July 29, 2010
Selective aldosterone blocker ameliorates the progression of non-alcoholic steatohepatitis in ratsRyuichi Noguchi, Hitoshi Yoshiji, Yasuhide Ikenaka, et al.
International Journal of Molecular Medicine|April 6, 2006
Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in ratsHitoshi Yoshiji, Shigeki Kuriyama, Ryuichi Noguchi, et al.
Thrombosis and Haemostasis|June 4, 2008
Comprehensive analysis of ADAMTS13 in patients with liver cirrhosisMasahito Uemura, Yoshihiro Fujimura, Masanori Matsumoto, et al.
Alcoholism, Clinical and Experimental Research|December 20, 2008
Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemiaMasatoshi Ishikawa, Masahito Uemura, Tomomi Matsuyama, et al.
Internal Medicine (Tokyo, Japan)|December 28, 2017
Glycogenic Hepatopathy in Type 1 Diabetes MellitusShohei Asada, Hideto Kawaratani, Tsuyoshi Mashitani, et al.
Journal of Gastroenterology|March 12, 2013
Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in ratsKosuke Kaji, Hitoshi Yoshiji, Yasuhide Ikenaka, et al.
Pageof 38